Brief: InDex Pharmaceuticals Q2 EBIT at SEK -86.9 Million
23/08/2023 07:02
Aug 23 (Reuters) - InDex Pharmaceuticals Q2 cash flow from operating activities SEK 80 million. * Q2 net income SEK 90 million * Q2 sales SEK 97.5 million * Q2 EBIT SEK -86.9 million